Skip to main content
Top
Published in: Annals of Surgical Oncology 4/2016

01-04-2016 | Melanomas

The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case–Control Study

Authors: Alastair D. MacKenzie Ross, MD, FRCS (Plast), Lauren E. Haydu, BSCHE, MIPH, Michael J. Quinn, MBBS, FRACS, Robyn P. M. Saw, MB, MS, FRACS, Kerwin F. Shannon, MBBS, FRACS, Andrew J. Spillane, MD, FRACS, Jonathan R. Stretch, MBBS, DPhil(Oxon), FRACS, Richard A. Scolyer, MD, FRCPA, FRCPath, John F. Thompson, MD, FRACS, FACS

Published in: Annals of Surgical Oncology | Issue 4/2016

Login to get access

Abstract

Background

At presentation, most primary cutaneous melanomas are “thin” (Breslow thickness ≤1 mm, designated T1 in the American Joint Committee on Cancer staging system) and local recurrence (LR) is rare. Most current management guidelines recommend 1 cm surgical excision margins for T1 melanomas, but evidence to support this recommendation is sparse. We sought to identify clinical and pathologic factors associated with LR in patients with T1 melanomas that might guide primary tumor management.

Methods

From a large, prospectively collected, single-institution database, patients with primary cutaneous melanomas ≤1 mm thick diagnosed between 1970 and 2011 who developed LR were identified and matched with controls. Clinical and pathologic parameters were analyzed for their association with LR.

Results

From 11,290 primary melanomas ≤1 mm thick, 176 (1.56 %) cases with LR were identified and 176 controls (without LR) were selected. LR occurred after a median time of 37 months (range 3–306 months) and was associated with narrower excision margins (hazard ratio = 0.95, 95 % confidence interval 0.92–0.98, p = 0.001), desmoplastic, acral, and lentigo maligna melanoma subtypes (p = 0.008), and melanomas composed predominantly of spindle cells (p = 0.005). However, Breslow thickness, Clark level, ulceration, mitotic rate, regression, and lymphovascular invasion were not.

Conclusions

LR was associated with <8 mm histologic excision margins (corresponding to <1 cm margins in vivo) and desmoplastic, acral, and lentigo maligna melanoma subtypes. This study provides evidence that a ≥1 cm clinical excision margin for thin (T1) primary melanomas reduces the risk of LR.
Literature
2.
go back to reference Green AC, Baade P, Coory M, et al. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia. J Clin Oncol. 2012;30:1462–7.CrossRefPubMed Green AC, Baade P, Coory M, et al. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia. J Clin Oncol. 2012;30:1462–7.CrossRefPubMed
3.
go back to reference Murali R, Haydu LE, Long GV, et al. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma. Ann Surg Oncol. 2012;19:1782–9.CrossRefPubMed Murali R, Haydu LE, Long GV, et al. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma. Ann Surg Oncol. 2012;19:1782–9.CrossRefPubMed
4.
go back to reference Kalady MF, White RR, Johnson JL, et al. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience. Ann Surg. 2003;238:528–35.PubMedPubMedCentral Kalady MF, White RR, Johnson JL, et al. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience. Ann Surg. 2003;238:528–35.PubMedPubMedCentral
5.
go back to reference Veronesi U, Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg. 1991;126:438–41.CrossRefPubMed Veronesi U, Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg. 1991;126:438–41.CrossRefPubMed
6.
go back to reference Khayat D, Rixe O, Martin G, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer. 2003;97:1941–6.CrossRefPubMed Khayat D, Rixe O, Martin G, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer. 2003;97:1941–6.CrossRefPubMed
7.
go back to reference Finley JW, Gibbs JF, Rodriguez LM, et al. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system. Am Surg. 2000;66:527–31.PubMed Finley JW, Gibbs JF, Rodriguez LM, et al. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system. Am Surg. 2000;66:527–31.PubMed
8.
go back to reference Gimotty PA, Guerry D. Prognostication in thin cutaneous melanomas. Arch Pathol Lab Med. 2010;134:1758–63.PubMed Gimotty PA, Guerry D. Prognostication in thin cutaneous melanomas. Arch Pathol Lab Med. 2010;134:1758–63.PubMed
9.
go back to reference Kittler H, Weitzdorfer R, Pehamberger H, et al. Compliance with follow-up and prognosis among patients with thin melanomas. Eur J Cancer. 2001;37:1504–9.CrossRefPubMed Kittler H, Weitzdorfer R, Pehamberger H, et al. Compliance with follow-up and prognosis among patients with thin melanomas. Eur J Cancer. 2001;37:1504–9.CrossRefPubMed
10.
go back to reference Leiter U, Buettner PG, Eigentler TK, et al. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the German Dermatological Society. J Clin Oncol. 2004;22:3660–7.CrossRefPubMed Leiter U, Buettner PG, Eigentler TK, et al. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the German Dermatological Society. J Clin Oncol. 2004;22:3660–7.CrossRefPubMed
11.
go back to reference Slingluff CL Jr, Seigler HF. “Thin” malignant melanoma: risk factors and clinical management. Ann Plast Surg. 1992;28:89–94.CrossRefPubMed Slingluff CL Jr, Seigler HF. “Thin” malignant melanoma: risk factors and clinical management. Ann Plast Surg. 1992;28:89–94.CrossRefPubMed
12.
go back to reference McKinnon JG, Starritt EC, Scolyer RA, et al. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or = 2 mm thick. Ann Surg. 2005;241:326–33.CrossRefPubMedPubMedCentral McKinnon JG, Starritt EC, Scolyer RA, et al. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or = 2 mm thick. Ann Surg. 2005;241:326–33.CrossRefPubMedPubMedCentral
13.
go back to reference Ng AK, Jones WO, Shaw JH. Analysis of local recurrence and optimizing excision margins for cutaneous melanoma. Br J Surg. 2001;88:137–42.CrossRefPubMed Ng AK, Jones WO, Shaw JH. Analysis of local recurrence and optimizing excision margins for cutaneous melanoma. Br J Surg. 2001;88:137–42.CrossRefPubMed
14.
go back to reference Stucky CC, Gray RJ, Dueck AC, et al. Risk factors associated with local and in-transit recurrence of cutaneous melanoma. Am J Surg. 2010;200:770–4.CrossRefPubMed Stucky CC, Gray RJ, Dueck AC, et al. Risk factors associated with local and in-transit recurrence of cutaneous melanoma. Am J Surg. 2010;200:770–4.CrossRefPubMed
15.
go back to reference Urist MM, Balch CM, Soong S, et al. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer. 1985;55:1398–402.CrossRefPubMed Urist MM, Balch CM, Soong S, et al. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer. 1985;55:1398–402.CrossRefPubMed
16.
go back to reference Månsson-Brahme E, Carstensen J, Erhardt K, et al. Prognostic factors in thin cutaneous malignant melanoma. Cancer. 1994;73:2324–32.CrossRefPubMed Månsson-Brahme E, Carstensen J, Erhardt K, et al. Prognostic factors in thin cutaneous malignant melanoma. Cancer. 1994;73:2324–32.CrossRefPubMed
17.
go back to reference Fearfield LA, Rowe A, Francis N, et al. Clinico-pathological features of relapsing very thin melanoma. Clin Exp Dermatol. 2001;26:686–95.CrossRefPubMed Fearfield LA, Rowe A, Francis N, et al. Clinico-pathological features of relapsing very thin melanoma. Clin Exp Dermatol. 2001;26:686–95.CrossRefPubMed
18.
go back to reference Kelly JW, Sagebiel RW, Calderon W, et al. The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. Ann Surg. 1984;200:759–63.PubMedPubMedCentral Kelly JW, Sagebiel RW, Calderon W, et al. The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. Ann Surg. 1984;200:759–63.PubMedPubMedCentral
19.
go back to reference Pasquali S, Haydu LE, Scolyer RA, et al. The importance of adequate primary tumor excision margins and sentinel node biopsy in achieving optimal locoregional control for patients with thick primary melanomas. Ann Surg. 2013;258:152–7.CrossRefPubMed Pasquali S, Haydu LE, Scolyer RA, et al. The importance of adequate primary tumor excision margins and sentinel node biopsy in achieving optimal locoregional control for patients with thick primary melanomas. Ann Surg. 2013;258:152–7.CrossRefPubMed
20.
go back to reference Harish V, Bond JS, Scolyer RA, et al. Margins of excision and prognostic factors for cutaneous eyelid melanomas. J Plast Reconstr Aesthet Surg. 2013;66:1066–73.CrossRefPubMed Harish V, Bond JS, Scolyer RA, et al. Margins of excision and prognostic factors for cutaneous eyelid melanomas. J Plast Reconstr Aesthet Surg. 2013;66:1066–73.CrossRefPubMed
21.
go back to reference Kerns MJ, Darst MA, Olsen TG, et al. Shrinkage of cutaneous specimens: formalin or other factors involved? J Cutan Pathol. 2008;35:1093–6.CrossRefPubMed Kerns MJ, Darst MA, Olsen TG, et al. Shrinkage of cutaneous specimens: formalin or other factors involved? J Cutan Pathol. 2008;35:1093–6.CrossRefPubMed
22.
go back to reference Guitart J, Lowe L, Piepkorn M, et al. Histological characteristics of metastasizing thin melanomas: a case–control study of 43 cases. Arch Dermatol. 2002;138:603–8.PubMed Guitart J, Lowe L, Piepkorn M, et al. Histological characteristics of metastasizing thin melanomas: a case–control study of 43 cases. Arch Dermatol. 2002;138:603–8.PubMed
23.
go back to reference Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE, et al. Outcomes of patients with local recurrence of cutaneous malignant melanoma: a population-based study. Cancer. 1997;80:1418–25.CrossRefPubMed Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE, et al. Outcomes of patients with local recurrence of cutaneous malignant melanoma: a population-based study. Cancer. 1997;80:1418–25.CrossRefPubMed
24.
go back to reference Griffiths RW, Briggs JC. Incidence of locally metastatic (“recurrent”) cutaneous malignant melanoma following conventional wide margin excisional surgery for invasive clinical stage I tumours: importance of maximal primary tumour thickness. Br J Surg. 1986;73:349–53.CrossRefPubMed Griffiths RW, Briggs JC. Incidence of locally metastatic (“recurrent”) cutaneous malignant melanoma following conventional wide margin excisional surgery for invasive clinical stage I tumours: importance of maximal primary tumour thickness. Br J Surg. 1986;73:349–53.CrossRefPubMed
25.
go back to reference Heenan PJ, English DR, Holman CD, et al. The effects of surgical treatment on survival and local recurrence of cutaneous malignant melanoma. Cancer. 1992;69:421–6.CrossRefPubMed Heenan PJ, English DR, Holman CD, et al. The effects of surgical treatment on survival and local recurrence of cutaneous malignant melanoma. Cancer. 1992;69:421–6.CrossRefPubMed
26.
go back to reference Lens MB, Newton-Bishop JA, Boon AP. Desmoplastic malignant melanoma: a systematic review. Br J Dermatol. 2005;152:673–8.CrossRefPubMed Lens MB, Newton-Bishop JA, Boon AP. Desmoplastic malignant melanoma: a systematic review. Br J Dermatol. 2005;152:673–8.CrossRefPubMed
27.
go back to reference Elder DE, Gimotty PA, Guerry D. Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features. Dermatol Ther. 2005;18:369–85.CrossRefPubMed Elder DE, Gimotty PA, Guerry D. Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features. Dermatol Ther. 2005;18:369–85.CrossRefPubMed
28.
go back to reference Heenan PJ. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanoma < or = 2 mm thick. Ann Surg. 2006;243:569.CrossRefPubMedPubMedCentral Heenan PJ. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanoma < or = 2 mm thick. Ann Surg. 2006;243:569.CrossRefPubMedPubMedCentral
30.
go back to reference MacCormack MA, Cohen LM, Rogers GS. Local melanoma recurrence: a clarification of terminology. Dermatol Surg. 2004;30:1533–8.PubMed MacCormack MA, Cohen LM, Rogers GS. Local melanoma recurrence: a clarification of terminology. Dermatol Surg. 2004;30:1533–8.PubMed
31.
go back to reference Zeitels J, LaRossa D, Hamilton R, et al. A comparison of local recurrence and resection margins for stage I primary cutaneous malignant melanomas. Plast Reconstr Surg. 1988;81:688–93.CrossRefPubMed Zeitels J, LaRossa D, Hamilton R, et al. A comparison of local recurrence and resection margins for stage I primary cutaneous malignant melanomas. Plast Reconstr Surg. 1988;81:688–93.CrossRefPubMed
Metadata
Title
The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case–Control Study
Authors
Alastair D. MacKenzie Ross, MD, FRCS (Plast)
Lauren E. Haydu, BSCHE, MIPH
Michael J. Quinn, MBBS, FRACS
Robyn P. M. Saw, MB, MS, FRACS
Kerwin F. Shannon, MBBS, FRACS
Andrew J. Spillane, MD, FRACS
Jonathan R. Stretch, MBBS, DPhil(Oxon), FRACS
Richard A. Scolyer, MD, FRCPA, FRCPath
John F. Thompson, MD, FRACS, FACS
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 4/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4942-0

Other articles of this Issue 4/2016

Annals of Surgical Oncology 4/2016 Go to the issue